Get started
Author

Tatjana Poplazarova

Observed name: Tatjana POPLAZAROVA
ORCID: 0000-0002-1121-0236
Observed ORCID: 0000-0002-1121-0236
OpenAlex ID: A5003868362
Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
2018 · Mary A. Ott, Francis P. Crawley, et al. · Pediatric Drugs · 18
PDF
Considerations for applying bioethics norms to a biopharmaceutical industry setting
2021 · The Biopharmaceutical Bioethics Working Group, Luann E. Van Campen, et al. · BMC Medical Ethics · 14
PDF
Publication practices and standards: recommendations from GSK Vaccines’ author survey
2014 · Isabelle Camby, Véronique Delpire, et al. · Trials · 11
PDF
Ethical decision-making in biopharmaceutical research and development: applying values using the TRIP & TIPP model
2020 · Tatjana Poplazarova, Claar van der Zee, et al. · Human Vaccines & Immunotherapeutics · 5
PDF
Recommendations for the ethical conduct of vaccination awareness campaigns by biopharmaceutical companies
2022 · Claar van der Zee, Veronique Delpire, et al. · Human Vaccines & Immunotherapeutics · 1
Thomas Breuer and colleagues at GlaxoSmithKline respond to Peter Doshi
2018 · Thomas Breuer, Vincent Bauchau, et al. · BMJ · 1
Outside in – inside out. Creating focus on the patient – a vaccine company perspective
2018 · Denis Sohy, Isabelle Dusart, et al. · Human Vaccines & Immunotherapeutics · 1
Oral Presentations Abstracts: FOUNDATIONAL ELEMENTS OF AN ETHICAL DECISION-MAKING MODEL APPLIED IN THE BIOPHARMACEUTICAL CONTEXT
2021 · Claar VAN DER ZEE, Tatjana POPLAZAROVA, et al. · Studia Universitatis Babeş-Bolyai Bioethica
Works count: 9
Citation count: 51
H-index: 4
I10-index: 3
Year
Topic
Type